Only one dosing exists on any label: the approved SCENESSE implant. It is a single controlled-release 16 mg afamelanotide implant, placed subcutaneously above the anterior supra-iliac crest by a trained clinician every 2 months, for adults with erythropoietic protoporphyria.[1]
Reviewed for accuracy · Last reviewed July 8, 2026The only regulated dosing is the approved EPP implant, placed by a trained clinician. There is no approved or standardized dose for tanning use.
There is no approved or standardized dose for using Melanotan-1 as an injectable tanning agent. Figures circulated in gray-market channels are anecdotal, come from no regulated source, and are not reproduced here as a titration table. Treat the approved implant dosing as a description of a clinician-administered product, not a protocol you can self-run.
Because Melanotan-1 (afamelanotide) is often confused with Melanotan II, note that any dosing you see attributed to "Melanotan" may in fact describe the different, more potent Melanotan II molecule.
This page is an independent educational reference and is not medical advice. The approval described applies only to the SCENESSE implant for erythropoietic protoporphyria, not to tanning use. Talk to a doctor before starting any compound.